Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia. It intends to treat thyroid cancer, improve lung cancer screening, and clarify the diagnosis of idiopathic pulmonary fibrosis. The company was founded by Bonnie H. Anderson and Y. Douglas Dolginow on August 15, 2006 and is headquartered in South San Francisco, CA.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
824
Frequently Asked Questions
What is Market Cap of Veracyte Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Veracyte Inc market cap is $2.52B.
What is the 52-week high for Veracyte Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Veracyte Inc 52 week high is $47.32 as of September 10, 2025.
What is the 52-week low for Veracyte Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Veracyte Inc 52 week low is $22.61 as of September 10, 2025.
What is Veracyte Inc stock price today?
Veracyte Inc stock price today is $30.82.
What was Veracyte Inc stock price yesterday?
Veracyte Inc stock price yesterday was $31.99.
What is the PE ratio of Veracyte Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Veracyte Inc’s P/E ratio is 96.15.
What is the Price-to-Book ratio of Veracyte Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Veracyte Inc P/B ratio is 2.0592.
What is the 50-day moving average of Veracyte Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Veracyte Inc 50-day moving average is $27.43.